Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
08/2003
08/06/2003EP1331937A2 Dibenzoxazepine alpha v integrin receptor antagonist
08/06/2003EP1331935A2 Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them
08/06/2003EP1331932A2 Therapeutic uses for ip 3? receptor-mediated calcium channel modulators
08/06/2003EP1173187B1 Combined preparations comprising morpholine anthracyclines and platinum derivatives
08/06/2003EP1165544B1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase
08/06/2003EP1117648B1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors
08/06/2003EP1117440B1 Pharmaceutical compositions containing paclitaxel
08/06/2003EP1109811B1 Pyrrolobenzodiazepines
08/06/2003EP0980381B1 Pharmaceutically acceptable salts of 5.alpha.-pregn-16-en-3.beta.-ol-20-one 3-sulphate ester with progestin activity and useful in the treatment of cns disorders
08/06/2003EP0821691B1 Methods of synthesizing gm2
08/06/2003EP0702563B1 Compositions and methods for treating cancer and hyperproliferative disorders
08/06/2003EP0695305B1 Method of forming oligonucleotides
08/06/2003CN1434870A Viral core protein-cationic lipid-nucleic acid-delivery complexes
08/06/2003CN1434862A Improvement of nucleic acid vaccination
08/06/2003CN1434832A DNA for encoding the RGI polypeptide
08/06/2003CN1434824A Bicyclic inhibitors of glycogen synthase kinase 3
08/06/2003CN1434823A 3-thiazol-4-yl-pyprolidine derivatives as AMP-specific phosphodiesterase inhibitors
08/06/2003CN1434822A Substituted oxazolidinones and their use in the field of blood coagulation
08/06/2003CN1434821A Quinazoline derivatives for the treatment of tumours
08/06/2003CN1434820A Cyclic AMP-specific phosphodiesterase inhibitors
08/06/2003CN1434818A Novel compounds
08/06/2003CN1434817A Pyrazole cyclic AMP-specific PDE inhibitors
08/06/2003CN1434813A Pyrrolidine derivatives cyclic AMP-specific phosphodiesterase inhibitors
08/06/2003CN1434811A New p2†ù7 receptor antagonists for use in the treatment of inflammatory immune or cardiovascular diseases
08/06/2003CN1434808A Novel branched substituted amino derivatives of 3-amino-1-phemyl-1HÒÇö1,2,4ÒÇò triazo, methods for producing them and pharmaceutica compositions containing them
08/06/2003CN1434807A Pyrazine based inhibitors of glycogen synthase kinase 3
08/06/2003CN1434799A Cyclic amp-specific phosphodiesterase inhibitors
08/06/2003CN1434798A Pyrrolidines which inhibit CAMP-specific PDE
08/06/2003CN1434797A Hydrazone and oxime derivatives of pyrrolidine as AMP-specific phosphodiesterase inhibitons
08/06/2003CN1434794A Adamantane derivatives
08/06/2003CN1434792A Purification of xanthophylls from marigold extracts that contain high levels of chlorophylls
08/06/2003CN1434727A Anglogenesis and vascular permeability modulators and inhibitors
08/06/2003CN1434718A Activation and inhibition of immune system
08/06/2003CN1434715A Pharmaceutical compositions
08/06/2003CN1434712A Nitrosated and nitrosylated cyclooxygenase-2 inhibitors compositions and methods of use
08/06/2003CN1434707A Method and compositions for preventing hormone induced adverse effects
08/06/2003CN1434705A Use of hydroxide-releasing agents as skin permeation enhancers
08/06/2003CN1434704A System and method for extended delivery of therapeutic agent with its receptor loading dose
08/06/2003CN1434119A Establishment and use of adult stem cell restitution hemopoiesis method of mesenchyme stem cell phynotype
08/06/2003CN1434054A Dowble-stranded RNA and use thereof
08/06/2003CN1434047A Calcarisporin B1 and extracting method and use in anti-tumor medicine
08/06/2003CN1434046A Novel intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof
08/06/2003CN1434044A Novel intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof
08/06/2003CN1434043A Novel intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof
08/06/2003CN1434041A Anti-tumor medicine and use thereof
08/06/2003CN1434040A Medicine with 1,6-methylene-[10]-annulene difuran and steroid basic structure and use thereof
08/06/2003CN1434037A Nove intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof
08/06/2003CN1433802A Chinese medicine for treating tumor and cancer
08/06/2003CN1433790A Use of Chinese herb peucedanum praeruptorum in preparation of medicine for treating tumor
08/06/2003CN1433780A Calcarisporium arbuscula alcohol extract preparation process and use in anti-tumor medicine
08/06/2003CN1117092C Azadicyclic compound, its medicinal composition and medicinal use
08/06/2003CN1117090C N-acryl-2-substituted-4-(benzimidazolyl-or-imidazopyridinyl-substituted pesidues)-piperidines as tachykinin antagonists
08/06/2003CN1117082C Substituted imidazoles having anti-cancer and cytokine inhibitory activity
08/06/2003CN1117081C Inhibition of raf kinase using aryl and hetroaryl substituted heterocyclic ureas
08/06/2003CN1117077C 6-phenylpyridyl-2-amine derivatives useful asNOS inhibitors
08/06/2003CN1117070C Aryl or heteroaryl amides of tetrahydronahpthalene, chroman, thiochroman and 1,2,3-tetrahydroquinoline carboxylic acids having retinoid-like biological activity
08/06/2003CN1116880C Use of puffer liver oil in preparing food for curing poisonous drug dependence
08/06/2003CN1116879C Process for preparing compound pancreatic ribonucleate for injection
08/06/2003CN1116875C Taxual-lipid composition and its preparing process
08/06/2003CN1116874C TPA injection and its producing technology
08/06/2003CN1116870C Applicatino of preventing and treating peripheral neurophathy by administering selegiline
08/05/2003US6603031 Vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents
08/05/2003US6603012 RAR selective retinoid agonists
08/05/2003US6603008 Sulfamoylheleroaryl pyrazole compounds as anti-inflammatory/analgesic agents
08/05/2003US6602910 Treating cancer in a patient comprising administering an effective amount of substantially purified D enantiomer of difluoromethylornithine
08/05/2003US6602903 Substituted heterocyclic compounds
08/05/2003US6602902 Dha-pharmaceutical agent conjugates to improve tissue selectivity
08/05/2003US6602883 Inhibitors of farnesyl protein transferase
08/05/2003US6602879 Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases
08/05/2003US6602878 Acylquanidine derivatives, method for preparing same, application as medicines and pharmaceutical compositions containing them
08/05/2003US6602876 Adhesion receptor antagonists
08/05/2003US6602874 5-(2-(4-methylpiperazin-1-yl)-phenyl)- furan-2-carboxylic acid 4-chlorobenzylamide, for example; treating or preventing migraine, depression and other disorders for which a 5-HT1, agonist or antagonist is indicated
08/05/2003US6602872 Substituted pyridazines having cytokine inhibitory activity
08/05/2003US6602864 Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds
08/05/2003US6602863 Irreversible inhibitors of tyrosine kinases
08/05/2003US6602857 Antisense modulation of PTP1B expression
08/05/2003US6602856 Antagonists of alpha-melanocyte stimulating hormone and methods based thereon
08/05/2003US6602709 Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells
08/05/2003US6602697 Process for purifying human papillomavirus virus-like particles
08/05/2003US6602684 Culturing a host cell to express a nucleic acid encoding beta (1,4)-N- acetylglucosaminyltransferase III under conditions for production of a polypeptide; can use to provide proteins with improved therapeutic properties
08/05/2003US6602670 Treating tumors; obtain tissue sample, isolate nucleotide sequences, amplify nucleotide sequences, monitor nucleotide sequence concentration of marker gene, compare to control
08/05/2003US6602506 Immunogenic composition; bactericidal
08/05/2003US6602503 Complementarity determining regions (CDRs); asthma and inflammatory bowel disease; integrins; antigen binding regions derived from the heavy and/ or light chain variable regions
08/05/2003US6602501 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
08/05/2003US6602274 Targeted transcutaneous cancer therapy
08/05/2003CA2362917C Methods for anti-tumor therapy
08/05/2003CA2264511C Compounds useful for inhibition of farnesyl protein transferase
08/05/2003CA2125490C Antimetastasis agent of malignant tumors
08/05/2003CA2082934C Phthalocyanatopolyethylene glycol, and phthalocyanato saccharides as fluorescent digoxin reagents
08/05/2003CA2075861C Dibenz[b,f][1,4]oxazepin-11(10h)-ones for multidrug resistance reversing agents
08/01/2003CA2418410A1 Novel, water-soluble porphyrin platinum compounds with high tumor selectivity and their use for the treatment of benign and malignant tumor diseases
07/2003
07/31/2003WO2003062830A2 Fibronectin variants and screening methods
07/31/2003WO2003062826A2 Materials and methods for examining and treating nasopharyngeal carcinoma
07/31/2003WO2003062447A2 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression
07/31/2003WO2003062421A1 Bispecific antisense olignucleotides that inhibit igfbp-2 and igfbp-5 and methods of using same
07/31/2003WO2003062414A2 Methods of obtaining isoform specific expression in mammalian cells
07/31/2003WO2003062413A1 Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis
07/31/2003WO2003062392A2 Methods of treating conditions associated with an edg receptor
07/31/2003WO2003062390A2 Compositions and methods for the modulation of sphingolipid metabolism and/or signaling
07/31/2003WO2003062279A1 Nutraceuticals for the treatment, protection and restoration of connective tissues
1 ... 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 ... 2211